A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of Paclitaxel Injection Concentrate for Nano-Dispersion (PICN) Versus Investigators Choice (IC) in Subjects With Advanced Biliary Tract Cancer (BTC)

Trial Profile

A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of Paclitaxel Injection Concentrate for Nano-Dispersion (PICN) Versus Investigators Choice (IC) in Subjects With Advanced Biliary Tract Cancer (BTC)

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 26 Oct 2016

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Biliary cancer
  • Focus Registrational; Therapeutic Use
  • Sponsors Sun Pharma Advanced Research Company
  • Most Recent Events

    • 20 Oct 2016 Planned End Date changed from 1 Nov 2019 to 1 Dec 2019.
    • 20 Oct 2016 Planned primary completion date changed from 1 Oct 2019 to 1 Dec 2019.
    • 20 Oct 2016 Planned initiation date changed from 1 Apr 2016 to 1 Dec 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top